Global Pricing Innovations

Global Pricing Innovations (GPI) is a pharmaceutical pricing intelligence firm that provides data, technology, and advisory services to help drug manufacturers navigate complex global pricing and market access challenges.

Reviewed by 7wData
Share Email

On this page

Profile

They provide pharmaceutical companies with data and tools to set and manage drug prices globally.

Global Pricing Innovations (GPI) is a pharmaceutical pricing intelligence firm that provides data, technology, and advisory services to help drug manufacturers navigate complex global pricing and market access challenges. The company specializes in aggregating and analyzing pharmaceutical pricing data from over 100 markets, including list prices, net pricing, rebates, and regulatory intelligence for policies like the Inflation Reduction Act (IRA) and Most Favored Nation (MFN) requirements. GPI's platform combines AI-powered analytics with predictive modeling to streamline pricing strategy workflows, offering features like instant international reference pricing (IRP) simulations and competitive tracking.

The firm serves a global clientele of pharmaceutical companies, with a focus on supporting pricing teams across executive leadership, regional leads, and local affiliates. While specific financials and headcount are not publicly disclosed, GPI has positioned itself as a trusted partner for pharmaceutical pricing strategy, evidenced by its client roster and proprietary data assets. The company's 2026 eBook highlights its focus on emerging policy shifts and market dynamics affecting drug pricing, suggesting a strategic emphasis on regulatory navigation and data-driven decision-making.

Track Global Pricing Innovations and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Global pharmaceutical manufacturers
  • Pricing and market access teams at biotech firms
  • Executive leadership overseeing drug commercialization
  • Regional and local affiliate teams managing country-specific pricing
  • Health economics and outcomes research (HEOR) professionals

Strengths and what to watch

Strengths

  • Proprietary datasets covering 100+ markets with validated pricing and rebate intelligence
  • AI-powered platform for real-time analytics and scenario modeling
  • Specialist expertise in navigating IRA, MFN, and other regulatory pricing policies

Watch for

  • Dependence on regulatory changes that could disrupt pricing models
  • Competition from larger healthcare data providers expanding into pricing analytics
  • Potential client concentration risk with a focus on pharmaceutical manufacturers

Recent moves

Key Information

Headquarters
London

Frequently Asked Questions

What does Global Pricing Innovations do?

Global Pricing Innovations (GPI) provides pharmaceutical companies with data, technology, and advisory services for global drug pricing. Their platform offers validated pricing intelligence from 100+ markets, AI analytics, and regulatory navigation tools for policies like the Inflation Reduction Act and Most Favored Nation requirements.

How does GPI help with pharmaceutical pricing strategy?

GPI's platform combines proprietary global pricing data with AI-powered analytics for scenario modeling. It enables instant international reference pricing simulations, competitive tracking, and predictive insights to help pharmaceutical teams optimize pricing strategies across different markets and regulatory environments.

What regulatory pricing policies does GPI specialize in?

GPI focuses on complex pharmaceutical pricing regulations including the Inflation Reduction Act (IRA) and Most Favored Nation (MFN) requirements. Their tools help manufacturers navigate policy shifts, analyze impacts, and maintain compliance across global markets through validated pricing intelligence and scenario modeling.

What types of pharmaceutical companies use GPI's services?

GPI serves global pharmaceutical manufacturers, biotech firms, and HEOR professionals. Their clients include executive leadership teams, pricing specialists, and local market affiliates who need accurate drug pricing data and strategy tools for commercialization across different regions.

How does GPI's pricing data compare to other providers?

GPI differentiates with proprietary datasets covering 100+ markets, including validated list prices, net pricing, and rebate intelligence. Their AI-powered platform offers real-time analytics and predictive modeling not always available from general healthcare data providers.

What are the latest trends in pharmaceutical pricing for 2026?

GPI's 2026 analysis highlights emerging policy shifts and market dynamics affecting drug pricing. Their research focuses on regulatory changes, international reference pricing evolution, and data-driven strategies to navigate complex global pricing environments, as detailed in their recent eBook publication.

Sources

  1. globalpricing.com — Company overview and service offerings
  2. info.globalpricing.com — 2026 pricing trends analysis and strategic focus
  3. www.biopharmadive.com — Regulatory context for pharmaceutical pricing
  4. www.biopharmadive.com — Policy environment affecting pharmaceutical pricing